These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4391559)

  • 1. Increased vascular permeability produced by human platelet granule cationic extract.
    Nachman RL; Weksler B; Ferris B
    J Clin Invest; 1970 Feb; 49(2):274-81. PubMed ID: 4391559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human platelet vascular permeability-enhancing activity.
    Nachman RL; Weksler B; Ferris B
    J Clin Invest; 1972 Mar; 51(3):549-56. PubMed ID: 4110899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic protein upon vascular permeability in the rat.
    Janoff A; Schaefer S; Scherer J; Bean MA
    J Exp Med; 1965 Nov; 122(5):841-51. PubMed ID: 4379082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of permeability factor obtained from the spleen.
    Davies HF; Hartley R; Schild HO
    Br J Pharmacol; 1972 Nov; 46(3):564P-565P. PubMed ID: 4120847
    [No Abstract]   [Full Text] [Related]  

  • 5. The platelet as an inflammatory cell.
    Nachman RL; Weksler B
    Ann N Y Acad Sci; 1972 Oct; 201():131-7. PubMed ID: 4119234
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization.
    Davis MD; Plager DA; George TJ; Weiss EA; Gleich GJ; Leiferman KM
    J Allergy Clin Immunol; 2003 Nov; 112(5):988-94. PubMed ID: 14610493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE; Brooks J; Burton JL; Archer CB
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediators of inflammation in leukocyte lysosomes. VII. Observations on mast cell-rupturing agents in different species.
    Scherer J; Janoff A
    Lab Invest; 1968 Feb; 18(2):196-202. PubMed ID: 5644534
    [No Abstract]   [Full Text] [Related]  

  • 11. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK; Boucher W; Pang X; Letourneau R; Seretakis D; Green M; Theoharides TC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1349-56. PubMed ID: 10027877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes.
    Niemetz J; Marcus AJ
    J Clin Invest; 1974 Dec; 54(6):1437-43. PubMed ID: 4612059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.
    Humphrey DM; McManus LM; Hanahan DJ; Pinckard RN
    Lab Invest; 1984 Jan; 50(1):16-25. PubMed ID: 6694349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
    García G; DeMora F; Ferrer L; Puigdemont A
    Am J Vet Res; 1997 Mar; 58(3):293-7. PubMed ID: 9055977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of permeability factors from rabbit neutrophils.
    Ranadive NS; Cochrane CG
    J Exp Med; 1968 Oct; 128(4):605-22. PubMed ID: 4175322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Permeability-increasing effect of punctates. 3. Inhibition of the permeability-increasing activity by contrykal].
    Leibe S; Wagner J
    Z Gesamte Inn Med; 1976 Mar; 31(6):172-5. PubMed ID: 941467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serratial protease causes vascular permeability reaction by activation of the Hageman factor-dependent pathway in guinea pigs.
    Kamata R; Yamamoto T; Matsumoto K; Maeda H
    Infect Immun; 1985 Jun; 48(3):747-53. PubMed ID: 2860069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granule-associated serine neutral proteases of the mouse bone marrow-derived mast cell that degrade fibronectin: their increase after sodium butyrate treatment of the cells.
    DuBuske L; Austen KF; Czop J; Stevens RL
    J Immunol; 1984 Sep; 133(3):1535-41. PubMed ID: 6205085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dehydroleucodine on histamine and serotonin release from mast cells in the isolated mouse jejunum.
    Penissi AB; Rudolph MI; Villar M; Coll RC; Fogal TH; Piezzi RS
    Inflamm Res; 2003 May; 52(5):199-205. PubMed ID: 12813624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.